A Study of Oral Contraception Under Simulated OTC Conditions
Public ClinicalTrials.gov record NCT03559010. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center Oral Contraceptive Pill Use Trial Conducted In an OTC Naturalistic Environment (OPTION)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to assess whether consumers select and use norgestrel 0.075 mg, a progestin only pill for contraception, in a manner consistent with the OTC package directions in an Over-the-Counter (OTC)-like setting.
Study identification
- NCT ID
- NCT03559010
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 189 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 27, 2018 (Actual)
- Primary completion
- Sep 9, 2018 (Actual)
- Completion
- Nov 14, 2018 (Actual)
- Last update posted
- Apr 4, 2022
2018
United States locations
- U.S. sites
- 44
- U.S. states
- 20
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HRA Pharma Investigational site | Birmingham | Alabama | 35215 | — |
| HRA Pharma Investigational site | Homewood | Alabama | 35209 | — |
| HRA Pharma Investigational site | McCalla | Alabama | 35111 | — |
| HRA Pharma Investigational site | Tucson | Arizona | 85704 | — |
| HRA Pharma Investigational site | Downey | California | 90241 | — |
| HRA Pharma Investigational site | La Habra | California | 90631 | — |
| HRA Pharma Investigational site | Long Beach | California | 90806 | — |
| HRA Pharma Investigational site | Los Angeles | California | 90005 | — |
| HRA Pharma Investigational site | Bridgeport | Connecticut | 06606 | — |
| HRA Pharma Investigational site | Hartford | Connecticut | 61121 | — |
| HRA Pharma Investigational site | New Haven | Connecticut | 65111 | — |
| HRA Pharma Investigational site | Riverview | Florida | 33578 | — |
| HRA Pharma Investigational site | Dalton | Georgia | 30721 | — |
| HRA Pharma Investigational site | Griffin | Georgia | 30224 | — |
| HRA Pharma Investigational site | Catonsville | Maryland | 21228 | — |
| HRA Pharma Investigational site | Anoka | Minnesota | 55303 | — |
| HRA Pharma Investigational site | Elk River | Minnesota | 55330 | — |
| HRA Pharma Investigational site | Fridley | Minnesota | 55432 | — |
| HRA Pharma Investigational Site | Saint Francis | Minnesota | 55070 | — |
| HRA Pharma Investigational site | Elsberry | Missouri | 63343 | — |
| HRA Pharma Investigational site | Manchester | Missouri | 63088 | — |
| HRA Pharma Investigational Site | Savannah | Missouri | 64485 | — |
| HRA Pharma Investigational site | Springfield | Missouri | 65807 | — |
| HRA Pharma Investigational site | Monroe | New Jersey | 08831 | — |
| HRA Pharma Investigational site | Albuquerque | New Mexico | 87104 | — |
| HRA Pharma Investigational site | Albuquerque | New Mexico | 87109 | — |
| HRA Pharma Investigational site | Albuquerque | New Mexico | 87110 | — |
| HRA Pharma Investigational site | Burlington | North Carolina | 27215 | — |
| HRA Pharma Investigational Site | South Charleston | Ohio | 45368 | — |
| HRA Pharma Investigational site | Bethlehem | Pennsylvania | 18015 | — |
| HRA Pharma Investigational site | Clarksville | Tennessee | 37043 | — |
| HRA Pharma Investigational site | Cleveland | Tennessee | 37311 | — |
| HRA Pharma Investigational site | Houston | Texas | 77008 | — |
| HRA Pharma Investigational site | Houston | Texas | 77099 | — |
| HRA Pharma Investigational site | Sherman | Texas | 75092 | — |
| HRA Investigational site | Bountiful | Utah | 84010 | — |
| HRA Pharma Investigational site | Mapleton | Utah | 84664 | — |
| HRA Pharma Investigational site | Syracuse | Utah | 84075 | — |
| HRA Pharma Investigational site | Montpelier | Virginia | 23192 | — |
| HRA Pharma Investigational site | Enumclaw | Washington | 98022 | — |
| HRA Pharma Investigational site | Kenmore | Washington | 98028 | — |
| HRA Pharma Investigational site | Seattle | Washington | 98117 | — |
| HRA Pharma Investigational site | Snohomish | Washington | 98290 | — |
| HRA Pharma Investigational site | Amery | Wisconsin | 54001 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03559010, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03559010 live on ClinicalTrials.gov.